Immunity to Oncogenic Proteins
- 1 June 1995
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 145 (1), 33-59
- https://doi.org/10.1111/j.1600-065x.1995.tb00076.x
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- Cytotoxic T Cells Isolated from Ovarian Malignant Ascites Recognize a Peptide Derived from the HER-2/neu Proto-oncogeneCellular Immunology, 1993
- Cytotoxic T-Cell Response and In Vivo Protection Against Tumor Cells Harboring Activated ras Proto-oncogenesJNCI Journal of the National Cancer Institute, 1993
- T Cell Recognition of Human Tumors: Implications for Molecular Immunotherapy of CancerClinical Immunology and Immunopathology, 1993
- T-cell responses against products of oncogenes: Generation and characterization of human T-cell clones specific for p21 ras-derived synthetic peptidesHuman Immunology, 1992
- Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC moleculesNature, 1991
- Identifying antigenic T-cell sitesNature, 1991
- In vitro and in vivo Release of Soluble erbB‐2 Protein from Human Carcinoma CellsJapanese Journal of Cancer Research, 1990
- Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genesCell, 1988
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Biological and biochemical properties of human rasH genes mutated at codon 61Cell, 1986